#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
David Schanzlin Email
Chief Medical Officer . Refocus
How to contact David Schanzlin
Join and see David's contact info for free!Current Roles
Employees:
32Revenue:
$8MAbout
Refocus Group, Inc. is a medical device company engaged in the research and development of treatments for human vision disorders. Our mission is to become the surgical standard of care for presbyopia. Refocus Group's latest product is the VisAbilityâ„¢ Implant System, which is used in an innovative procedure known as the VisAbilityâ„¢ Procedure. The implant is an investigational device and is not yet approved for sale or use in the United States or Canada. However, the product is currently approved for sale in the European Union.Refocus Address
10210 N CENTRAL EXPYDallas, TX
United States